Joy Hardison, MD
General Practice · Houston, TXNPI 1851520688
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Merz North America, Inc. accounts for 64.2% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for general practice clinicians in TX, where the typical reported total is $213.
Across 3 payments — averaging $42.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$81
- Brainscope Company, Inc.$25
- Linus Health, Inc.$21
What the payments were for
- Food & beverage$127100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 1 | $81 |
| Brainscope Company, Inc. | 1 | $25 |
| Linus Health, Inc. | 1 | $21 |
How this compares
$127 in reported general payments places this provider in the 35th percentile of 8,074 general practice providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $13,277 |
| Liothyronine Sodium | 39 | $1,628 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $1,053 |
| Levothyroxine Sodium | 79 | $945 |
| Atorvastatin Calcium | 67 | $834 |
| Valsartan | 26 | $668 |
| Bupropion XlBupropion Hcl | 25 | $454 |
| Rosuvastatin Calcium | 28 | $418 |
| Amlodipine Besylate | 51 | $406 |
| Losartan Potassium | 35 | $325 |
| Escitalopram Oxalate | 39 | $320 |
| Alprazolam | 37 | $270 |
| Trazodone Hcl | 35 | $242 |
| Tamsulosin Hcl | 25 | $184 |
| Meloxicam | 16 | $179 |
Paid to pharmacies, not to this prescriber.
Other general practice in Houston
- Kathleen Szelei-StevensHouston$253K
- Zsolt GaramiHouston$111K
- Scott ColemanHouston$87K
- Rispba McCray-GarrisonHouston$70K
- Piya GandhiHouston$36K
- Terri AlaniHouston$30K
- Demetris GreenHouston$26K
- Steven XueHouston$19K
- Carol DupuisHouston$16K
- Rosita HamidiHouston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.